Subsection | Requirement |
Pregnancy | • Information relevant to the use of the drug in pregnant women, such as dosing and potential risks to the developing fetus • Information about whether there is a registry that collects and maintains data on how pregnant women are affected when they use the drug or biological product. • Subheadings addressing: “risk summary”, “clinical considerations”, and “data”. |
Lactation | • Information about using the drug while breastfeeding, such as the amount of drug in breast milk and potential effects on the breastfed child. • Subheadings addressing: “risk summary”, “clinical considerations”, and “data”. |
Females and Males of Reproductive Potential | • Information about pregnancy testing, contraception and about infertility as it relates to the drug. |
There is no firm evidence that the penicillins, metronidazole, azithromycin, and clindamycin are teratogenic in humans. Animal studies have revealed no evidence of harm to the fetus; however, there are no adequate and well-controlled studies in pregnant women.34,37,61,70,77,149 Since animal studies are not always predictive of a drug’s teratogenic effect in humans, antibacterial agents should only be prescribed during pregnancy if clearly indicated.34,37,61,70,77,149
Your session is about to expire. Do you want to continue logged in?
WARNING! You did not finish creating your certificate. Please click CONTINUE below to return to your previous page to complete the process. Failure to complete ALL the steps will result in a loss of this test score, and you will not receive credit for this course.